Page last updated: 2024-11-11

biotinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

biotinate : Conjugate base of biotin arising from deprotonation of the carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6560210
CHEBI ID57586

Synonyms (14)

Synonym
2C1Q
biotinate
biotinate anion
CHEBI:57586
5-[(3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl]pentanoate
5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate
3EFR
3RDO
2JGS
2ZSC
3EW2
2UYW
4DVE
Q27124798
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
cofactorAn organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
monocarboxylic acid anionA carboxylic acid anion formed when the carboxy group of a monocarboxylic acid is deprotonated.
vitamin B7Any member of a group of vitamers that belong to the chemical structural class called biotins that exhibit biological activity against vitamin B7 deficiency. Vitamin B7 deficiency is very rare in individuals who take a normal balanced diet. Foods rich in biotin are egg yolk, liver, cereals, vegetables (spinach, mushrooms) and rice. Symptoms associated with vitamin B7 deficiency include thinning hair, scaly skin rashes around eyes, nose and mouth, and brittle nails. The vitamers include biotin and its ionized and salt forms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (25)

PathwayProteinsCompounds
biotin-carboxyl carrier protein assembly110
lathyrine biosynthesis07
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
leucine degradation1221
superpathway of allantoin degradation in yeast415
pyruvate fermentation to propanoate I618
indole-3-acetate biosynthesis VI (bacteria)219
3-hydroxypropanoate/4-hydroxybutanate cycle1840
biotin-carboxyl carrier protein assembly615
2-oxobutanoate degradation I1028
cis-genanyl-CoA degradation421
reductive TCA cycle II1024
L-glutamate degradation V (via hydroxyglutarate)726
L-leucine degradation I2026
gluconeogenesis II (Methanobacterium thermoautotrophicum)1542
jadomycin biosynthesis1127
Methanobacterium thermoautotrophicum biosynthetic metabolism2279
urea degradation I111
lathyrine biosynthesis110
superpathway of L-methionine salvage and degradation2869
urea degradation111
biotin biosynthesis from 8-amino-7-oxononanoate I013
biotin biosynthesis from 8-amino-7-oxononanoate212
biotin biosynthesis III015
biotin biosynthesis II314
biotin biosynthesis I315
biotin biosynthesis from 7-keto-8-aminopelargonate012

Protein Targets (11)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Circular Permutant Of AvidinGallus gallus (chicken)Kd0.24000.24000.24000.2400AID977611
Chain B, Circular Permutant Of AvidinGallus gallus (chicken)Kd0.24000.24000.24000.2400AID977611
Chain A, XenavidinXenopus tropicalis (tropical clawed frog)Kd0.00000.00000.00000.0000AID977611
Chain A, Tamavidin2Pleurotus cornucopiae (cornucopia mushroom)Kd0.08700.08700.08700.0870AID977611
Chain B, Tamavidin2Pleurotus cornucopiae (cornucopia mushroom)Kd0.08700.08700.08700.0870AID977611
Chain A, Biotin [acetyl-CoA-carboxylase] ligaseAquifex aeolicusKd8.30004.60006.45008.3000AID977611
Chain A, Biotin [acetyl-CoA-carboxylase] ligaseAquifex aeolicusKd8.30004.60006.45008.3000AID977611
Chain A, rhizavidinRhizobium etli CFN 42Kd0.21500.21500.21500.2150AID977611
Chain A, StreptavidinStreptomyces avidiniiKd0.00010.00010.00010.0001AID977611
Chain A, StreptavidinStreptomyces avidiniiKd0.00010.00010.00010.0001AID977611
Chain A, Biotin transporter BioYLactococcus cremoris subsp. cremoris MG1363Kd0.00030.00030.00030.0003AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009Journal of molecular biology, Mar-20, Volume: 387, Issue:1
Structural and functional studies of the biotin protein ligase from Aquifex aeolicus reveal a critical role for a conserved residue in target specificity.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009BMC structural biology, Sep-29, Volume: 9Structural and functional characteristics of xenavidin, the first frog avidin from Xenopus tropicalis.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2012Proceedings of the National Academy of Sciences of the United States of America, Aug-28, Volume: 109, Issue:35
Structural divergence of paralogous S components from ECF-type ABC transporters.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2008Chembiochem : a European journal of chemical biology, May-05, Volume: 9, Issue:7
Rational modification of ligand-binding preference of avidin by circular permutation and mutagenesis.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2011Protein science : a publication of the Protein Society, Jul, Volume: 20, Issue:7
Evolved streptavidin mutants reveal key role of loop residue in high-affinity binding.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009Journal of molecular biology, Feb-20, Volume: 386, Issue:2
Crystal structure of rhizavidin: insights into the enigmatic high-affinity interaction of an innate biotin-binding protein dimer.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009The FEBS journal, Mar, Volume: 276, Issue:5
Tamavidins--novel avidin-like biotin-binding proteins from the Tamogitake mushroom.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.94 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index77.38 (26.88)
Search Engine Supply Index3.95 (0.95)

This Compound (32.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]